PMID: 9447503Feb 3, 1998Paper

The use of risperidone for psychosis and agitation in demented patients with Parkinson's disease

The Journal of Neuropsychiatry and Clinical Neurosciences
R H WorkmanM E Kunik

Abstract

This pilot study investigated effectiveness and tolerability of risperidone for the treatment of psychosis and agitation in 9 inpatients with Parkinson's disease and dementia. Investigators found risperidone to be effective and safe, without worsening extrapyramidal symptoms or further impairing cognition.

Citations

Dec 1, 2012·Acta Neuropsychiatrica·Massimo GalleraniRoberto Manfredini
Mar 20, 2002·Current Neurology and Neuroscience Reports·E S Molho, S A Factor
Jun 8, 2001·Current Treatment Options in Neurology·David B. ArciniegasLauren Frey
Sep 16, 2010·Current Treatment Options in Neurology·Laura B Zahodne, Hubert H Fernandez
Mar 22, 2006·Expert Opinion on Investigational Drugs·Kelvin L Chou, Hubert H Fernandez
Sep 17, 2002·Journal of Geriatric Psychiatry and Neurology·Joseph H Friedman, Hubert H Fernandez
Dec 5, 2000·Movement Disorders : Official Journal of the Movement Disorder Society·E MohrP P De Deyn
Apr 7, 2000·Movement Disorders : Official Journal of the Movement Disorder Society·J H Friedman, S A Factor
Feb 24, 2001·International Clinical Psychopharmacology·I Schweitzer
Mar 6, 2003·Journal of Clinical Pharmacology·Qinying ZhaoJean-Loup Parier
Feb 15, 2007·Journal of Palliative Medicine·Jennifer KapoSolomon Liao
Jan 24, 2019·Current Treatment Options in Neurology·Kasia Gustaw Rothenberg, Ryan Rajaram
Jul 31, 2008·Drugs & Aging·Laura B Zahodne, Hubert H Fernandez
Feb 19, 2008·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Unax LertxundiJuan Carlos García-Moncó
Jan 5, 2002·CNS Drugs·Daniel TarsyFrank I Tarazi
Jun 20, 2003·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Hubert H FernandezJoseph H Friedman
Jan 6, 2012·The Neurologist·Oscar Bernal-PachecoHubert H Fernandez
May 23, 2014·Expert Opinion on Pharmacotherapy·Leora L Borek, Joseph H Friedman
May 15, 2015·Clinical Neuropharmacology·Unax LertxundiJuan Carlos García-Moncó
Jan 15, 2015·Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Österreichischer Nervenärzte und Psychiater·Jacopo Vittoriano BizzarriHans Peter Kapfhammer
Nov 27, 2018·Journal of Parkinson's Disease·John R YounceKevin J Black
Feb 9, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·Stewart A FactorJoseph H Friedman
Aug 9, 2019·Current Psychiatry Reports·Jeffrey CummingsKasia Rothenberg
Sep 1, 2011·Progress in Neurobiology·Philippe HuotJonathan M Brotchie

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Nederlands tijdschrift voor geneeskunde
J Schouten, O A Stravers
The Journal of Neuropsychiatry and Clinical Neurosciences
M C IrizarryJ H Growdon
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
Bruce G PollockKimberly A Huber
© 2021 Meta ULC. All rights reserved